Crucifixion (van Dyck) Crucifixion (van Dyck) The Crucifixion is an oil on canvas painting by Anthony van Dyck, produced around 1630. It is 2.51 m high. It was originally commissioned as the high altar-piece in the convent of the Récollets in Lille during van Dyck's second Antwerp period, between his return from Italy in 1627 and his departure for London in 1632. It returned to a theme he had already painted around 1617-19 during his first Antwerp period, when he was still a studio-assistant to Rubens - this was "Crucifixion with the Virgin Mary, St John and St Mary Magdalene", sold to Rubens
Christopher H. van Dyck Disease. Using SPECT imaging of the Dopamine transporter, van Dyck’s work has shown that there is loss of dopamine from the aging striatum, and that this is related to a slowing of reaction time, a measure of mental chronometry. van Dyck uses PET imaging to track Alzheimer’s-related pathology, to learn how pathology relates to ApoEApoE genotype, and whether it is diminished by potential treatments. Dr. van Dyck has collaborated with Dr. Richard Carson at the Yale PET Center to test the new PET ligand 11C-UCB-J, which binds to SV2A to provide an assay of presynaptic axon terminals in the human